FDA approves expanded indication for Novartis Leqvio (inclisiran) to include treatment of adults with high LDL-C and who are at increased risk of heart disease Read more
SK bioscience- Government Pharmaceutical Organization Sign Memorandum of Understanding to Strengthen Vaccine Infrastructure in Thailand Read more
Astellas Announces FDA Grants Priority Review for Zolbetuximab Biologics License Application Read more
FDA approves Jardiance (empagliflozin) for the treatment of type 2 diabetes in children 10 years and older Read more